Howton David T (CIK 0001529297)

Latest company ownership

Shares held
63,943
Last filed at
Dec 4, 2025
Confidence Score
47.1
2025Q4
Confidence Score History
2023Q4 2025Q4
SRPT - Sarepta Therapeutics, Inc.
Role: EVP, General Counsel
Shares held
45,000
Last filed at
Jun 22, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 2, 2025 Dec 4, 2025 Solid Biosciences Inc. COO Sell 46.3 -4,932 -13.03% ✗ $25.2K
Feb 13, 2025 Feb 18, 2025 Solid Biosciences Inc. COO Sell 46.3 -5,561 -18.32% ✗ $22K
Dec 2, 2024 Dec 4, 2024 Solid Biosciences Inc. COO Sell 46.3 -5,072 -24.46% ✗ $28.4K
Dec 2, 2023 Dec 5, 2023 Solid Biosciences Inc. COO Sell 13.8 -5,367 -41.12% ✓ $14.9K
Jun 22, 2020 Jun 22, 2020 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 2.5 -105,122 -76.74% ✓ $18M
Dec 13, 2019 Dec 17, 2019 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 3.8 -78,000 -75.60% ✓ $9.8M
Nov 22, 2019 Nov 26, 2019 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 5.0 -27,804 -28.19% ✓ $2.9M
Mar 28, 2019 Mar 29, 2019 Sarepta Therapeutics, Inc. EVP, General Counsel Sell 97.5 +2,957 18.78% ✗ $280.3K
Feb 1, 2019 Feb 1, 2019 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 5.0 -30,000 -60.52% ✓ $4.2M
Aug 8, 2018 Aug 8, 2018 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 40.0 -6,800 -19.50% ✗ $822.9K
Jul 16, 2018 Jul 17, 2018 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 3.8 -50,000 -32.34% ✓ $6.8M
May 22, 2018 May 24, 2018 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 42.5 -1,566 -4.30% ✗ $139.7K
Mar 15, 2018 Mar 16, 2018 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 32.5 -680 -0.75% ✗ $55.2K
Aug 3, 2017 Aug 7, 2017 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 42.5 -4,642 -13.68% ✗ $175.8K
Jul 20, 2017 Jul 21, 2017 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 5.0 -25,000 -35.92% ✓ $1M
Mar 19, 2017 Mar 21, 2017 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 50.0 -152 -0.68% ✗ $4.6K
Sep 22, 2016 Sep 26, 2016 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 12.5 -7,000 -24.60% ✓ $420K
Sep 19, 2016 Sep 21, 2016 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 97.5 +10,285 92.09% ✓ $465.2K
Aug 31, 2016 Sep 2, 2016 Sarepta Therapeutics, Inc. SVP, General Counsel Sell 46.3 -898 -22.09% ✗ $23.4K